Aradigm Corporation Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
Sales 2016 | 195K 266K | Sales 2017 | 14.46M 19.74M | Capitalization | 97.3M 133M |
---|---|---|---|---|---|
Net income 2016 | -32M -43.68M | Net income 2017 | -10M -13.65M | EV / Sales 2016 | 73.3 x |
Net cash position 2016 | 9.37M 12.79M | Net Debt 2017 | 7.91M 10.8M | EV / Sales 2017 | 7.27 x |
P/E ratio 2016 |
-0.72
x | P/E ratio 2017 |
-9.3
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 60.28% |
1st Jan change | Capi. | |
---|---|---|
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |